Search

01/05/2023 EndoTrainer: a novel hybrid training platform for endoscopic surgery
Hernansanz A., Rovira R., Basomba J., Comas R., Casals A.. EndoTrainer: a novel hybrid training platform for endoscopic surgery. International Journal of Computer Assisted Radiology and Surgery. 2023; 18(5)DOI:10.1007/s11548-023-02837-x. PMID:36781742. IF:2.300(Q2/3D).
01/01/2023 Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study
Rodriguez-Vida, A, Maroto, P, Font, A, Martin, C, Mellado, B, Corbera, A, Orrillo, M, Reig, O, Querol, R, Rios-Hoyo, A, Cano, L, Alonso, J, Martinez, G, Galtes, S, Taus, A, Martinez-Garcia, M, Juanpere, N, Juan, O, Bellmunt, J. Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study. BRITISH JOURNAL OF CANCER. 2023; 128(1)DOI:10.1038/s41416-022-01991-4. PMID:36289372. IF:6.400(Q1/2D).
01/01/2023 Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis
Labidi-Galy S.I., Rodrigues M., Sandoval J.L., Kurtz J.E., Heitz F., Mosconi A.M., Romero I., Denison U., Nagao S., Vergote I., Parma G., Nøttrup T.J., Rouleau E., Garnier G., El-Balat A., Zamagni C., Martín-Lorente C., Pujade-Lauraine E., Fiévet A., Ray-Coquard I.L.. Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis. ANNALS OF ONCOLOGY. 2023; 34(2)DOI:10.1016/j.annonc.2022.11.003. PMID:36564284. IF:56.700(Q1/1D).
01/01/2023 Comparison of laparoscopy and laparotomy in the management of early-stage ovarian cancer
Garcia N.G., Moreno C.S., Teixeira N., Lloret P.E., Guibourg R., Negre R.R.. Comparison of laparoscopy and laparotomy in the management of early-stage ovarian cancer. GYNECOLOGY AND MINIMALLY INVASIVE THERAPY-GMIT. 2023; 12(2)DOI:10.4103/gmit.gmit_99_22. PMID:37416098. IF:(Q/D).